• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因多态性与衰竭患者的 fractalkine、 fractalkine 受体和 C 反应蛋白水平的关联。

Association of Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure.

机构信息

Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.

出版信息

Int J Environ Res Public Health. 2021 Feb 23;18(4):2202. doi: 10.3390/ijerph18042202.

DOI:10.3390/ijerph18042202
PMID:33672355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7926901/
Abstract

Fractalkine () is a chemokine that plays a significant role in inflammation, one of the pathophysiological processes underlying end-stage renal disease (ESRD). Genetic factors are significantly involved in cytokine expression and have been studied as potential risk factors for chronic kidney disease (CKD). : We aimed to elucidate the association of gene polymorphisms rs3732378 and rs3732379 with the levels of , receptor (), as well as C-reactive protein (CRP). : We enrolled 198 participants, including 106 patients with ESRD and 92 controls. Peripheral blood samples were collected from each patient for genetic (rs3732378 and rs3732379 polymorphisms) and immunoenzymatic (fractalkine, , CRP) tests. : and CRP levels were higher in patients with ESRD than in controls ( < 0.05). Fractalkine levels were significantly higher in ESRD patients who were homozygous for the G allele of the rs3732378 polymorphism and for the C allele of the rs3732379 polymorphism than in homozygous controls. Moreover, carriers of these alleles among patients with ESRD had significantly higher levels than controls. : The G allele of the rs3732378 polymorphism and the C allele of the rs3732379 polymorphism of the gene are associated with higher and levels. Our study suggests that gene polymorphisms could be potentially involved in the pathogenesis of ESRD, but the study needs to be replicated in a larger population with a longitudinal follow-up study. Identification of genetic factors associated with inflammation in ESRD may contribute to the development of targeted gene therapies in the future.

摘要

趋化因子()在炎症中起着重要作用,而炎症是终末期肾病()的病理生理过程之一。遗传因素在细胞因子表达中起着重要作用,并被研究为慢性肾病()的潜在危险因素。:我们旨在阐明基因多态性与水平、受体()以及 C 反应蛋白()之间的关联。:我们纳入了 198 名参与者,包括 106 名终末期肾病患者和 92 名对照。从每位患者采集外周血样进行遗传(rs3732378 和 rs3732379 多态性)和免疫酶(趋化因子、、CRP)检测。:与对照组相比,终末期肾病患者的和 CRP 水平更高(<0.05)。与 rs3732378 多态性的 GG 纯合子和 rs3732379 多态性的 CC 纯合子相比,rs3732378 多态性的 GG 纯合子和 rs3732379 多态性的 CC 纯合子的患者的趋化因子水平明显更高。此外,与对照组相比,这些等位基因携带者的水平明显更高。:基因 rs3732378 多态性的 G 等位基因和 rs3732379 多态性的 C 等位基因与水平升高相关。我们的研究表明,基因多态性可能与终末期肾病的发病机制有关,但需要在更大的人群中进行复制,并进行纵向随访研究。鉴定与终末期肾病炎症相关的遗传因素可能有助于未来开发针对基因的治疗方法。

相似文献

1
Association of Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure.基因多态性与衰竭患者的 fractalkine、 fractalkine 受体和 C 反应蛋白水平的关联。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2202. doi: 10.3390/ijerph18042202.
2
Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.循环 fractalkine(CX3CL1)和 CX3CR1(+)CD4(+)T 细胞与慢性肾脏病患者颈总动脉内膜中层厚度的关系。
J Atheroscler Thromb. 2011;18(11):958-65. doi: 10.5551/jat.8722. Epub 2011 Aug 27.
3
Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? fractalkine (CX3CL1)及其受体 CX3CR1:慢性肾脏病的有前途的治疗靶点?
Front Immunol. 2021 Jun 7;12:664202. doi: 10.3389/fimmu.2021.664202. eCollection 2021.
4
Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.结直肠癌患者中趋化因子受体CX3CR1的多态性及其配体CX3CL1的血浆水平
Int J Colorectal Dis. 2007 Oct;22(10):1195-200. doi: 10.1007/s00384-007-0343-6. Epub 2007 Jul 5.
5
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.趋化因子fractalkine在克罗恩病中的表达增加以及趋化因子受体T280M多态性与纤维狭窄性疾病表型的关联。
Am J Gastroenterol. 2006 Jan;101(1):99-106. doi: 10.1111/j.1572-0241.2005.00361.x.
6
Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.趋化因子受体CX3CR1 V249I和T280M基因多态性与慢性肾脏病的关联
Indian J Nephrol. 2016 Jul-Aug;26(4):275-9. doi: 10.4103/0971-4065.163426.
7
Fractalkine is a novel human adipochemokine associated with type 2 diabetes. fractalkine 是一种新型的人脂肪细胞趋化因子,与 2 型糖尿病有关。
Diabetes. 2011 May;60(5):1512-8. doi: 10.2337/db10-0956.
8
Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.趋化因子受体CX3CR1基因中的两种多态性影响动脉粥样硬化的发展:一项荟萃分析。
Dis Markers. 2014;2014:913678. doi: 10.1155/2014/913678. Epub 2014 Aug 26.
9
The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.趋化因子CX3CL1(fractalkine)及其受体CX3CR1:在骨关节炎中的存在情况及潜在作用
Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):395-403. doi: 10.1007/s00005-014-0275-0. Epub 2014 Feb 21.
10
CX3CR1 polymorphisms associated with an increased risk of developmental dysplasia of the hip in human.CX3CR1基因多态性与人类髋关节发育不良风险增加相关。
J Orthop Res. 2017 Feb;35(2):377-380. doi: 10.1002/jor.23294. Epub 2016 Jun 14.

引用本文的文献

1
CX3CR1-Fractalkine Dysregulation Affects Retinal GFAP Expression, Inflammatory Gene Induction, and LPS Response in a Mouse Model of Hypoxic Retinopathy.CX3CR1-趋化因子失调影响缺氧性视网膜病变小鼠模型中的视网膜GFAP表达、炎症基因诱导及LPS反应。
Int J Mol Sci. 2025 Jan 28;26(3):1131. doi: 10.3390/ijms26031131.
2
A double-edged sword: interactions of CXCL1/CXCR1 and gut microbiota in systemic lupus erythematosus.一把双刃剑:CXCL1/CXCR1 与肠道微生物群在系统性红斑狼疮中的相互作用。
Front Immunol. 2024 Jan 17;14:1330500. doi: 10.3389/fimmu.2023.1330500. eCollection 2023.
3
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.CX3CL1会加重心肾功能障碍,并成为卡格列净治疗心肾综合征的一个治疗靶点。
Front Pharmacol. 2022 Mar 18;13:848310. doi: 10.3389/fphar.2022.848310. eCollection 2022.
4
CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients.埃及患者中CX3CR1基因V249M和T280M位点的基因多态性及其与终末期肾病的潜在风险
Int J Nephrol. 2021 Apr 24;2021:6634365. doi: 10.1155/2021/6634365. eCollection 2021.

本文引用的文献

1
A guide to chemokines and their receptors.趋化因子及其受体指南。
FEBS J. 2018 Aug;285(16):2944-2971. doi: 10.1111/febs.14466. Epub 2018 Apr 24.
2
Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma.趋化因子/ CX3CL1通过CX3CR1/PI3K/Akt/NF-κB通路诱导人骨肉瘤中细胞间黏附分子-1依赖性肿瘤转移。
Oncotarget. 2016 Aug 12;8(33):54136-54148. doi: 10.18632/oncotarget.11250. eCollection 2017 Aug 15.
3
Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).硫酸吲哚酚(IS)介导的免疫功能障碍会引发终末期肾病(ESRD)患者的内皮损伤。
Sci Rep. 2017 Jun 8;7(1):3057. doi: 10.1038/s41598-017-03130-z.
4
Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.趋化因子受体CX3CR1 V249I和T280M基因多态性与慢性肾脏病的关联
Indian J Nephrol. 2016 Jul-Aug;26(4):275-9. doi: 10.4103/0971-4065.163426.
5
Inflammation and Progression of CKD: The CRIC Study.慢性肾脏病的炎症与进展:慢性肾脏病队列研究(CRIC研究)
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1546-1556. doi: 10.2215/CJN.13121215. Epub 2016 Jun 23.
6
Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.慢性肾衰竭血液透析患者中趋化因子受体(CX3CR1)和CCR5基因变异与高血压、糖尿病及动脉粥样硬化的相关性
Int Urol Nephrol. 2016 Jul;48(7):1163-70. doi: 10.1007/s11255-016-1293-0. Epub 2016 Apr 27.
7
Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?神经系统中的趋化因子:神经保护分子还是神经毒性分子?
Ann N Y Acad Sci. 2015 Sep;1351:141-8. doi: 10.1111/nyas.12805. Epub 2015 Jun 17.
8
Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.趋化因子受体CX3CR1基因中的两种多态性影响动脉粥样硬化的发展:一项荟萃分析。
Dis Markers. 2014;2014:913678. doi: 10.1155/2014/913678. Epub 2014 Aug 26.
9
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.慢性肾脏病的评估与管理:肾脏病:改善全球预后 2012 临床实践指南概要。
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
10
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.慢性肾脏病与心血管风险:流行病学、发病机制与预防。
Lancet. 2013 Jul 27;382(9889):339-52. doi: 10.1016/S0140-6736(13)60595-4. Epub 2013 May 31.